NCT07230262 Trial Comparing Multiport RObotic and Laparoscopic Surgery for Elective Colorectal Resections in IBD Patients (ACRO-IBD)
| NCT ID | NCT07230262 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Universitaire Ziekenhuizen KU Leuven |
| Condition | IBD - Inflammatory Bowel Disease |
| Study Type | INTERVENTIONAL |
| Enrollment | 110 participants |
| Start Date | 2025-10-01 |
| Primary Completion | 2028-05-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 110 participants in total. It began in 2025-10-01 with a primary completion date of 2028-05-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of this study is to better understand whether robotic surgery leads to better outcomes than laparoscopy in terms of complications, recovery and quality of life.
Eligibility Criteria
Inclusion Criteria: 1. Voluntary written informed consent of the participant or their legally authorized representative has been obtained prior to any screening procedures 2. At least 18 years of age at the time of signing the Informed Consent Form (ICF) 3. Diagnosed with IBD and eligible for elective minimally invasive colorectal surgery, including: 1.4 Ileocecal/ileocolic resections 1.5 Segmental colectomies 1.6 Total colectomy 1.7 Proctocolectomy 1.8 Proctectomy 4. Procedures involving primary anastomosis or temporary or permanent stoma creation 5. Suitable for minimally invasive surgery Exclusion Criteria: 1. Non IBD patients 2. Urgent surgery (\<24 hours from hospital admission) 3. Not suitable for minimally invasive surgery 4. Ileoanal pouch construction
Contact & Investigator
Gabriele Bislenghi, Professor
PRINCIPAL INVESTIGATOR
UZ Leuven
Frequently Asked Questions
Who can join the NCT07230262 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying IBD - Inflammatory Bowel Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07230262 currently recruiting?
Yes, NCT07230262 is actively recruiting participants. Contact the research team at isabelle.terrasson@uzleuven.be for enrollment information.
Where is the NCT07230262 trial being conducted?
This trial is being conducted at Leuven, Belgium.
Who is sponsoring the NCT07230262 clinical trial?
NCT07230262 is sponsored by Universitaire Ziekenhuizen KU Leuven. The principal investigator is Gabriele Bislenghi, Professor at UZ Leuven. The trial plans to enroll 110 participants.